Owner BioMarin Pharmaceutical Inc.

Inventors Wendt, Daniel J.; Aoyagi-Scharber, Mika; Long, Shinong; Vellard, Michel Claude; Castillo, Sianna; Okhamafe, Augustus O.; Price, Christopher P.

Agent Wrays

Pub. Number AU-A-2010249802

PCT Pub. Number WO2010/135541

Priority 61/180,112 20.05.09 US; 61/254,563 23.10.09 US

Filing date 20 May 2010

Wipo publication date 25 November 2010

C07K 7/00 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/10 (2006.01) Medicinal preparations containing peptides - Peptides having 12 to 20 amino acids

A61K 38/16 (2006.01) Medicinal preparations containing peptides - Peptides having more than 20 amino acids

A61K 49/00 (2006.01) Preparations for testing

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

A61P 13/12 (2006.01) Drugs for disorders of the urinary system

A61P 19/00 (2006.01) Drugs for skeletal disorders

C07K 14/00 (2006.01) Peptides having more than 20 amino acids

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12P 21/06 (2006.01) Preparation of peptides or proteins - produced by the hydrolysis of a peptide bond, e.g. hydrolysate products

C12Q 1/42 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving phosphatase

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids